Recent advances in the epidemiology, diagnosis, and management of Trichomonas vaginalis infection
- PMID: 31583080
- PMCID: PMC6758837
- DOI: 10.12688/f1000research.19972.1
Recent advances in the epidemiology, diagnosis, and management of Trichomonas vaginalis infection
Abstract
Trichomonas vaginalis is the most common, curable non-viral sexually transmitted infection (STI) worldwide. Despite this burden of disease, it is not currently a reportable disease in the United States. Recent advances in the epidemiology, diagnosis, and management of T. vaginalis infection are described in this article. This includes updated global and U.S. prevalence data in women and men as well as recent epidemiological data in HIV-infected individuals and pregnant women. Advances in molecular diagnostics are also reviewed, as are data from recent clinical trials regarding the treatment of trichomonas in women.
Keywords: STI; Trichomonas vaginalis; vaginal infections.
Copyright: © 2019 Van Gerwen OT and Muzny CA.
Conflict of interest statement
Competing interests: Christina A. Muzny is a consultant for Lupin Pharmaceuticals, BioFire Diagnostics, and Cepheid. She has also received honoraria from Roche Diagnostics and Becton Dickinson. Olivia T. Van Gerwen declares that she has no competing interests.No competing interests were disclosed.No competing interests were disclosed.
References
-
- Krieger JN: Trichomoniasis in men: Old issues and new data. Sex Transm Dis. 1995;22(2):83–96. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
